期刊文献+

环丙沙星体外诱导肺炎链球菌耐药机制研究 被引量:1

Molecular mechanism of ciprofloxacin drug resistance in Streptococcus pneumoniae induced in vitro
原文传递
导出
摘要 目的探讨环丙沙星体外诱导肺炎链球菌耐药的分子机制。方法10株临床分离的肺炎链球菌体外用不同浓度梯度环丙沙星逐级诱导成为耐药株,检测诱导前后菌株对环丙沙星的MICs,PCR扩增诱导前后菌株parC/parE和gyrA/gyrB基因喹诺酮耐药决定区(QRDR)、测序并与GenBank公布序列比对。结果8株临床菌株成功诱导为耐药株,诱导后MICs是诱导前16倍以上,诱导后2株只发现parC/parE基因的QRDR有突变其耐药水平较低MICs分别为8μg/ml和16μg/ml,6株parC/parE和gyrA/gyrB基因的QRDR同时存在点突变耐药水平较高,MICs分别为64μg/ml和128μg/ml。结论逐步增加药物浓度可以诱导肺炎链球菌parC/parE和/或gyrA/gyrB基因的QRDR点突变导致对环丙沙星耐药。 Objective To investigate the molecular mechanisms of ciprofloxacin(Cip)resistance in S.pneumoniae induced in vitro.Methods A total of 10 S.pneumoniae isolates was induced to become drug-resistant strains with different concentrations of gradient ciprofloxacin in vitro.The MICs of ciprofloxacin of isolates before and after induction was detected.The quinolone resistance determining regions(QRDR)of the parC/parE and gyr A/gyr B genes of the strains before and after induction of PCR amplification were sequenced and compared with the sequences published in Gen Bank.Results MIC values of 8 isolates after induction were 16 times higher than induced before,which were induced to drug resistant strains successfully and also resistant to Cip.Mutations of QRDR of only parC/parE genes were detected by sequencing in 2 isolates,and the MICs with low drug resistance level were 8μg/ml and 16μg/ml respectively.The QRDR of parC/parE and gyr A/gyrB genes simultaneously had point mutation in 6 isolates and the MICs with high resistance level were 64μg/ml and 128μg/ml.Conclusion Gradual increase in drug concentration can induce QRDR point mutations in the parC/parE and/or gyr A/gyrB genes of S.pneumoniae,resulting in resistance to ciprofloxacin.
作者 舒媚 孙爱华 王家学 SHU Mei;SUN Ai-hua;WANG Jia-xue(Yongkang Hospital of Traditional Chinese Medicine,Yongkang,Zhejiang 321300,China;不详)
出处 《中国卫生检验杂志》 CAS 2020年第2期129-131,140,共4页 Chinese Journal of Health Laboratory Technology
基金 国家自然科学基金项目(81772232) 浙江省自然科学基金项目(LY16H190006)。
关键词 肺炎链球菌 环丙沙星 耐药 体外 诱导 S.pneumoniae Ciprofloxacin Drug resistant Vitro Induction
  • 相关文献

参考文献8

二级参考文献93

  • 1崔俊昌,刘又宁,王睿,梁蓓蓓,裴斐,郑专杰.4种氟喹诺酮类药物对金黄色葡萄球菌的防耐药变异浓度[J].中华医学杂志,2004,84(22):1863-1866. 被引量:34
  • 2崔俊昌,刘又宁,王睿,梁蓓蓓.氟喹诺酮药物对金黄色葡萄球菌同源耐药突变株的耐药突变选择窗研究[J].中国抗生素杂志,2006,31(4):212-215. 被引量:11
  • 3李朝霞,刘又宁,王睿,崔俊昌,程仕虎,童卫杭.氟喹诺酮类药物对金黄色葡萄球菌及其耐药突变体的耐药性研究[J].中国临床药理学与治疗学,2006,11(6):696-701. 被引量:17
  • 4van Doom HR, An DD, de Jong MD, et al. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe zeal-time PCR [ J ] . hat J Tuberc Lung Dis, 2008, 12(7) : 736-742.
  • 5Sirgel FA, Warren RM, Streicher EM, et al. gyrA mutations and phenotypie susceptibility levels to otloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis [ J ]. J Antimicrob Chemother, 2012, 67(5):1088-1093.
  • 6National committee for clinical laboratory standards. Susceptibility testing of Myeobacteria, aocardiae, and other aerobic actinomycetes; approved standard [ M ]. West Valley Road, Wayne:Clinical and Laboratory Standards Institute, 2003.
  • 7Michea-Hamzehponr M, Kahr A, Pechere JC. In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial Gram-negative bacilli[ J] . Infection, 1994, Suppl 2 : S105-110.
  • 8Siddiqi S, Takhar P, Baldeviano C, et al. Isoniazid induces its own resistance in nonreplicating Mycobaeterium tuberculosis [ J ]. Antimicrob Agents Chemother, 2007, 51 (6) :2100-2104.
  • 9Malik M, Chavda K, Zhao X, et al. Induction of mycobacterial resistance to quinolone crass antimicrobials [ J ] . Antimicroh Agents Chemother, 2012, 56(7):3879-3887.
  • 10Sun Z, Zhang J, Zhang X, et al. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates[ J] . Int J Antimicrob Agents, 2008, 31 (2) : 115-121.

共引文献65

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部